Nanotechnology - Enhanced CRISPR-Cas9 Epigenome Editing for Cancer Therapy: Innovations in Delivery, Targeting and Safety

Study Overview: This systematic review examines the integration of nanotechnology with CRISPR-Cas9 systems for targeted epigenome editing in cancer therapy. The study addresses critical gaps in current research by evaluating how various nanoparticle-based delivery systems enhance the precision, efficacy, and safety of CRISPR-Cas9 applications for cancer treatment. Research Objectives: Examine the role of nanotechnology in enhancing CRISPR-Cas9 delivery and specificity for epigenome editing in cancer therapy Evaluate recent nanotechnology-based innovations aimed at reducing systemic toxicity and improving safety profiles Assess targeting strategies and therapeutic outcomes across different cancer models Methodology: Systematic literature search across PubMed, Scopus, and Nature databases (2014-2024) Keywords: "CRISPR-Cas9 epigenome editing", "nanotechnology-enhanced CRISPR delivery", "cancer-targeted epigenome editing", "CRISPR-Cas9 safety in cancer therapy" Focus on peer-reviewed articles with empirical data on safety, efficacy, and delivery mechanisms Key Findings: The review identifies five major nanoparticle platforms: Lipid Nanoparticles (LNPs) with enhanced endosomal escape capabilities Polymeric Nanoparticles (PLGA) with tumor-targeting ligands Gold Nanoparticles (AuNPs) combining photothermal therapy with gene editing Metal-Organic Frameworks (MOFs) enabling high-capacity intracellular delivery Magnetic Nanoparticles (MNPs) providing externally controlled targeting Clinical Relevance: This research contributes to developing safer, more precise cancer therapies by addressing delivery challenges and off-target effects that limit clinical translation of CRISPR-Cas9 technology. Publication Status: Published in Proceedings of the 15th International Conference on Sustainable Built Environment (ICSBE) 2024 Data Sharing: This project contains the complete methodology, data extraction protocols, analysis frameworks, and supplementary materials used in the systematic review to ensure reproducibility and transparency in research.

Publication Details

Journal
Open Science Framework
Published
2025-01-01
DOI
https://doi.org/10.17605/osf.io/qeku5
Primary Topic
CRISPR and Genetic Engineering
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Nanotechnology - Enhanced CRISPR-Cas9 Epigenome Editing for Cancer Therapy: Innovations in Delivery, Targeting and Safety

Open Science Framework
CRISPR and Genetic Engineering
article

Nanotechnology - Enhanced CRISPR-Cas9 Epigenome Editing for Cancer Therapy: Innovations in Delivery, Targeting and Safety

article en

Abstract

Study Overview: This systematic review examines the integration of nanotechnology with CRISPR-Cas9 systems for targeted epigenome editing in cancer therapy. The study addresses critical gaps in current research by evaluating how various nanoparticle-based delivery systems enhance the precision, efficacy, and safety of CRISPR-Cas9 applications for cancer treatment. Research Objectives: Examine the role of nanotechnology in enhancing CRISPR-Cas9 delivery and specificity for epigenome editing in cancer therapy Evaluate recent nanotechnology-based innovations aimed at reducing systemic toxicity and improving safety profiles Assess targeting strategies and therapeutic outcomes across different cancer models Methodology: Systematic literature search across PubMed, Scopus, and Nature databases (2014-2024) Keywords: "CRISPR-Cas9 epigenome editing", "nanotechnology-enhanced CRISPR delivery", "cancer-targeted epigenome editing", "CRISPR-Cas9 safety in cancer therapy" Focus on peer-reviewed articles with empirical data on safety, efficacy, and delivery mechanisms Key Findings: The review identifies five major nanoparticle platforms: Lipid Nanoparticles (LNPs) with enhanced endosomal escape capabilities Polymeric Nanoparticles (PLGA) with tumor-targeting ligands Gold Nanoparticles (AuNPs) combining photothermal therapy with gene editing Metal-Organic Frameworks (MOFs) enabling high-capacity intracellular delivery Magnetic Nanoparticles (MNPs) providing externally controlled targeting Clinical Relevance: This research contributes to developing safer, more precise cancer therapies by addressing delivery challenges and off-target effects that limit clinical translation of CRISPR-Cas9 technology. Publication Status: Published in Proceedings of the 15th International Conference on Sustainable Built Environment (ICSBE) 2024 Data Sharing: This project contains the complete methodology, data extraction protocols, analysis frameworks, and supplementary materials used in the systematic review to ensure reproducibility and transparency in research.

Open Science Framework
Industry, innovation and infrastructure
Openalex Percentile: Top 52%
CRISPR and Genetic Engineering
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Nanotechnology - Enhanced CRISPR-Cas9 Epigenome Editing for Cancer Therapy: Innovations in Delivery, Targeting and Safety · Open Science Framework (2025) | TGRS Research Map | TGRS